Yong-Man Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yong-Man Park has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Won-Bae Chang
Department of Surgery, Jeju National University Hospital, Jeju National University College of Medicine, Jeju, Korea
2 shared publications - Dong In Kim
Sungkyunkwan University
1 shared publication - Donghyoun Lee
Department of Surgery, Jeju National University Hospital, Jeju National University School of Medicine
1 shared publication - Hyo-Shin Kim
Division of Vascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
1 shared publication - Jaemin Jo
Department of Internal Medicine, Jeju National University Hospital, Jeju National University College of Medicine, Jeju, Korea
1 shared publication - Jeong Rae Yoo
Department of Internal Medicine, Jeju National University College of Medicine, Jeju, Korea
1 shared publication
Latest Publications
- Open Access
- 17 March 2025
- Published by Korean Society for Stem Cell Research in International Journal of Stem Cells
- Vol. 18 (3) , 254-262
A Phase 1/2a Clinical Trial to Evaluate the Efficacy and Safety of Allogenic Adipose Tissue-Derived Mesenchymal Stem Cell Clusters in Patients with Critical Limb Ischemia
Yong-Man Park, Joon-Kee Park, Hyo-Shin Kim, Shin-Seok Yang, Jong-Wan Kim, Dong-Ik Kim. IJSC -0001;0:. https://doi.org/10.15283/ijsc25002
- 17 March 2025
- Published by Korean Society for Stem Cell Research in International Journal of Stem Cells
- Vol. 18 (3) , 254-262
Open AccessA Phase 1/2a Clinical Trial to Evaluate the Efficacy and Safety of Allogenic Adipose Tissue-Derived Mesenchymal Stem Cell Clusters in Patients with Critical Limb Ischemia
Yong-Man Park, Joon-Kee Park, Hyo-Shin Kim, Shin-Seok Yang, Jong-Wan Kim, Dong-Ik Kim. IJSC -0001;0:. https://doi.org/10.15283/ijsc25002
- Open Access
- 1 January 2025
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 108 (6) , 362-366
Comparison of outcomes for chemo-port implantation performed in the operating room and interventional radiology suite: a retrospective observational study
Park YM, et al. Ann Surg Treat Res. 2025 Jun;108(6):362-366. https://doi.org/10.4174/astr.2025.108.6.362
- 1 January 2025
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 108 (6) , 362-366
Open AccessComparison of outcomes for chemo-port implantation performed in the operating room and interventional radiology suite: a retrospective observational study
Park YM, et al. Ann Surg Treat Res. 2025 Jun;108(6):362-366. https://doi.org/10.4174/astr.2025.108.6.362
- Open Access
- 31 July 2022
- Published by Korean Society of Acute Care Surgery in JOURNAL OF ACUTE CARE SURGERY
- Vol. 12 (2) , 77-81
Multiple Surgical Treatments for Recurrent Retroperitoneal Hemorrhage in a COVID-19 Patient with Respiratory Failure on Extracorporeal Membrane Oxygenation
Extracorporeal membrane oxygenation (ECMO) may be required in patients with corona virus disease-19 (COVID-19) and respiratory failure. Anticoagulation is the standard treatment to prevent complications of ECMO and COVID-19 coagulopathy, however, there is a risk of bleeding. Some patients with retroperitoneal hemorrhage (RPH) have been treated with angiography-embolization. We report on a patient with COVID-19 on ECMO who underwent multiple operations (×5) for recurrent RPH. A 46-year-old man was admitted with COVID-19 pneumonia. ECMO with anticoagulation therapy was initiated. The patient developed RPH, caused by external compression of the inferior vena cava interrupting the ECMO inflow, and surgical hematoma evacuation was performed, with no obvious bleeding focus during the multiple surgeries. Following the patient’s recovery, a follow-up computed tomography scan showed the hematoma had been resolved, but there was a dilemma regarding anticoagulation. Lowering the threshold for surgical treatment, enabled treatment of a patient with serious RPH.
- 31 July 2022
- Published by Korean Society of Acute Care Surgery in JOURNAL OF ACUTE CARE SURGERY
- Vol. 12 (2) , 77-81
Open AccessMultiple Surgical Treatments for Recurrent Retroperitoneal Hemorrhage in a COVID-19 Patient with Respiratory Failure on Extracorporeal Membrane Oxygenation
Extracorporeal membrane oxygenation (ECMO) may be required in patients with corona virus disease-19 (COVID-19) and respiratory failure. Anticoagulation is the standard treatment to prevent complications of ECMO and COVID-19 coagulopathy, however, there is a risk of bleeding. Some patients with retroperitoneal hemorrhage (RPH) have been treated with angiography-embolization. We report on a patient with COVID-19 on ECMO who underwent multiple operations (×5) for recurrent RPH. A 46-year-old man was admitted with COVID-19 pneumonia. ECMO with anticoagulation therapy was initiated. The patient developed RPH, caused by external compression of the inferior vena cava interrupting the ECMO inflow, and surgical hematoma evacuation was performed, with no obvious bleeding focus during the multiple surgeries. Following the patient’s recovery, a follow-up computed tomography scan showed the hematoma had been resolved, but there was a dilemma regarding anticoagulation. Lowering the threshold for surgical treatment, enabled treatment of a patient with serious RPH.